NSN 6505-01-696-1705 · NIIN 016961705 · FSC 6505
NO DASHES 6505016961705
In Stock
MIDAZOLAM NASAL SPRAY
Drugs and Biologicals
Technical characteristics
3 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| FEAT | SPECIAL FEATURES | INDICATED FOR THE ACUTE TREATMENT OF INTERMITTENT, STEREOTYPIC EPISODES OF FREQUENT SEIZURE ACTIVITY (I.E., SEIZURE CLUSTERS, ACUTE REPETITIVE SEIZURES) THAT ARE DISTINCT FROM A PATIENT'S USUAL SEIZURE PATTERN IN PATIENTS WITH EPILEPSY 12 YEARS OF AGE AND OLDER; SUPPLIED AS A SINGLE-DOSE NASAL SPRAY UNIT CONTAINING 5 MG OF MIDAZOLAM IN 0.1 ML SOLUTION; SUPPLIED IN BOXES OF 2 NASAL SPRAY UNITS, EACH CONTAINED WITHIN AN INDIVIDUAL BLISTER PACK; DO NOT OPEN THE BLISTER PACKAGING UNTIL READY TO USE; STORE AT CONTROLLED ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F), EXCURSIONS PERMITTED TO 15 C TO 30 C (59 F TO 86 F); SHELF LIFE: 12 MONTHS. |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | MIDAZOLAM NASAL SPRAY, 2S |
| CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
Cross-references
3 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| 6505NCM217197 | 64616 |
| 1597620 | 89875 |
| NDC50474-0500-15 | 0S423 |